Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VANIthis companyVivani Medical, Inc.	$1.13	-2.86×	4.88×	0×	-3.03×	-104.3%	0.0%	0.0%	0.0%	-169.2%	-79.7%	-33.2%	1.2×	-0.1×	0×	2.71×	0.0%	2	-4.57	1	D+
HYPRHyperfine, Inc.	$0.70	-2.28×	2.25×	6.8×	-1.67×	-270.1%	49.8%	-273.4%	-262.3%	-86.8%	-84.7%	-31.6%	0.01×	1.01×	0×	4.34×	0.0%	4	-6.81	1	C-
IMAImageneBio Inc	$4.16	-0.72×	0.28×	46.85×	-0.28×	9.5%	-29.1%	-6056.4%	-5668.6%	-34.1%	-33.4%	-127.6%	0.08×	0.56×	0×	12.49×	0.0%	1	0.37	3	B
MBOTMicrobot Medical Inc.	$1.14	-6.9×	1.18×	0×	-6.76×	-93.0%	0.0%	0.0%	0.0%	-16.9%	-18.8%	-14.3%	0.01×	0.23×	0×	23.33×	0.0%	2	8.03	2	C+
NSPRInspireMD, Inc.	$0.65	-2.34×	2.37×	14.56×	-2.59×	-939.0%	29.5%	-547.0%	-543.3%	-88.4%	-82.2%	-28.1%	0.06×	0.12×	0×	5.74×	0.0%	2	-11.16	2	C+
ORMPOramed Pharmaceuticals Inc.	$3.97	1.86×	0.59×	59×	0.97×	-70.9%	0.7%	-754.4%	3202.5%	32.1%	-6.0%	-9.4%	0×	-0.6×	0×	6.98×	0.0%	3	3.38	5	S-
Peer median	—	-2.28×	1.18×	14.56×	-1.67×	-93.0%	0.7%	-547.0%	-262.3%	-34.1%	-33.4%	-28.1%	0.01×	0.23×	0×	6.98×	0.0%	2	0.37	2	—